Answers are grounded in this paper and cite their sources.
This document provides the 2017 ESC focused update on the use of dual antiplatelet therapy in patients with coronary artery disease.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Valgimigli et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: